FDA DEVICE FACTS
LUOFUCON® Wound Matrix
Huizhou Foryou Medical Devices Co., Ltd.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
LUOFUCON® Wound Matrix is indicated to cover and protect a wound. Page 2 / 5
The LUOFUCON®Wound Matrix is intended for the management of: partial and full-thickness wounds pressure ulcers venous ulcers diabetic ulcers chronic vascular ulcers surgical wounds (donor sites/grafts, post-Moh’s surgery, post-laser surgery, podiatric, wound dehiscence) trauma wounds (abrasions, lacerations, skin tears) partial thickness burns draining wounds. LUOFUCON® Wound Matrix is intended for adults except for those who are allergic to poly(lactic-co-glycolic acid) or polyethylene glycol.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。